Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- PLSE
- Price
- 23.67
- Stock movement up
- +0.66 (2.87%)
- Company name
- Pulse Biosciences Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Instruments & Supplies
- Market cap
- 1.60B
- Ent value
- 1.52B
- Price/Sales
- 621.25
- Price/Book
- 17.30
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -16.53%
- 1 year return (CAGR)
- 10.56%
- 3 year return (CAGR)
- 96.28%
- 5 year return (CAGR)
- -9.57%
- 10 year return (CAGR)
- -
Last updated: 2026-02-20
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
PLSE does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 621.25 |
| Price to Book | 17.30 |
| EV to Sales | 590.59 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 67.77M |
| EPS (TTM) | -1.11 |
| FCF per share (TTM) | -0.72 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 2.58M |
| Gross profit (TTM) | 89.00K |
| Operating income (TTM) | -78.95M |
| Net income (TTM) | -74.73M |
| EPS (TTM) | -1.11 |
| EPS (1y forward) | -1.66 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 3.45% |
| Operating margin (TTM) | -3057.59% |
| Profit margin (TTM) | -2894.38% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 95.21M |
| Net receivables | 15.00K |
| Total current assets | 97.16M |
| Goodwill | 2.79M |
| Intangible assets | 741.00K |
| Property, plant and equipment | 11.65M |
| Total assets | 108.77M |
| Accounts payable | 2.98M |
| Short/Current long term debt | 7.89M |
| Total current liabilities | 9.70M |
| Total liabilities | 16.07M |
| Shareholder's equity | 92.69M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -48.51M |
| Capital expenditures (TTM) | 263.00K |
| Free cash flow (TTM) | -48.77M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -80.62% |
| Return on Assets | -68.71% |
| Return on Invested Capital | -79.32% |
| Cash Return on Invested Capital | -51.77% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 22.98 |
| Daily high | 24.22 |
| Daily low | 22.93 |
| Daily Volume | 303K |
| All-time high | 44.27 |
| 1y analyst estimate | 22.00 |
| Beta | 1.78 |
| EPS (TTM) | -1.11 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PLSE | S&P500 | |
| Current price drop from All-time high | -46.53% | -1.82% |
| Highest price drop | -97.22% | -56.47% |
| Date of highest drop | 30 Aug 2022 | 9 Mar 2009 |
| Avg drop from high | -60.11% | -10.84% |
| Avg time to new high | 42 days | 12 days |
| Max time to new high | 1262 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
1.60B
Marketcap category
Small-cap
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; CellFX nsPFA Percutaneous Electrode system for soft tissue ablation in surgical setting; CellFX nsPFA Cardiac Clamp designed for use in surgical treatment of atrial fibrillation (AF); CellFX nsPFA 360° Cardiac Catheter designed to provide a circumferential, or circular, ablation in a single treatment cycle; and The CellFX Consol, a tunable, software-enabled, and console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Employees
75
Investor relations
-
SEC filings
CEO
Darrin R. Uecker
Country
USA
City
Hayward
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page